Skip to main content

AI and Healthcare: Opportunities and Challenges| Book Publisher International

 In the dynamic world of healthcare, a revolutionary transformation is underway, heralded by the integration of Artificial Intelligence (AI). This book delves deep into the essence of AI, beginning with a comprehensive introduction that demystifies what AI truly is, clarifies the distinction between AI, Machine Learning, and Deep Learning, and provides a handy AI Keyword Glossary for easy understanding. As we journey through the history of AI, we encounter the AI boom, marking a pivotal shift in how technology influences our lives.

 

Venturing into the Marvelous World of AI, we explore its capabilities in learning, vision, and language understanding, alongside a deep dive into AI systems, architecture, and the intricacies of designing an AI product. The narrative then transitions into AI's profound influence on various industries, with a special focus on healthcare. Through an overview of global healthcare systems, the book lays the groundwork for understanding the fundamental elements and challenges within healthcare, setting the stage for AI's transformative potential.

 

As we navigate the future of healthcare, the role of AI technology becomes unmistakably central, acting as a super detective in diagnostics, enhancing patient engagement, and accelerating drug discovery among its numerous applications. The book further explores the intricate relationship between AI and healthcare data, shedding light on machine learning models, their applications, advantages, and limitations within the healthcare context.

 

Diving into the building blocks of healthcare data security, we address the sensitivity of healthcare data, regulatory challenges, and the implementation of robust security measures. Real-world applications exemplify AI's practicality, while emerging technologies such as Blockchain and the Internet of Medical Things (IoMT) hint at the future landscape.

 

A pivotal chapter on AI and healthcare ethics, equity, and regulation underscores the importance of ethical AI, patient consent, privacy, and the ongoing battle against AI bias. Through case studies and examples, including IBM Watson for Oncology and Google DeepMind's partnership with the NHS, the narrative illustrates both triumphs and trials in the AI healthcare domain.

 

The journey continues with a glimpse into the future, emphasizing the development of an AI-ready healthcare workforce, the role of government and policy in shaping AI in healthcare, and a call to action for stakeholders. The book concludes with reflections on the future prospects of AI in healthcare, painting a picture of a landscape where AI and human expertise converge to create a more efficient, equitable, and innovative healthcare system.

 

Through this exploration, "The Rise of Generative AI: From DeepFakes to Creative Arts" offers readers a comprehensive guide to understanding and navigating the complex yet promising world of AI in healthcare. It serves as a beacon for professionals, policymakers, and enthusiasts alike, illuminating the path towards a future where technology and healthcare unite to enhance the human experience.


Author(s) Details:

Kulbir Singh,
University of Illinois Urbana-Champaign, Champaign, IL, USA.

Please see the link here: https://stm.bookpi.org/AHOC/article/view/14035
Labels:

Comments

Post a Comment

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)
Post a Comment
Read more

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system
Post a Comment
Read more

Ethnopharmacological Survey among Traditional Medicine Practitioners in Abidjan (Côte d'Ivoire) for the Management of Pathologies such as Malaria, ENT Diseases, Diarrhea, Typhoid Fever and Anemia | Chapter 05 | New Horizons in Medicine and Medical Research Vol. 8

 Traditional Medicine Practitioners (TMPs) of Côte d'Ivoire are familiar with the therapeutic herbs. Medicinal plants have been shown to be useful in the treatment of common diseases such as malaria (KROA, 2004) and diabetes (N'GUESSAN et al, 2013) in several studies and scientific study. In the Abidjan District, the current policy is to integrate traditional medicine and pharmacopoeia into the national health system in order to improve population health coverage, particularly in the management of commonly encountered diseases such as malaria, ENT diseases, diarrhoea, typhoid fever, and anaemia. This research aims to increase the use of traditional medicine and pharmacopoeia in the national health system. Over the course of three months, fifty (50) PMTs in the District of Abidjan participated in this study. Plant therapists accounted for 30 of the 50 PMTs polled at the end of the study, or 60%. Traditional medicine centres use 61 types of medicinal plants from 36 famili
Post a Comment
Read more